You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
31 March 2021
Takeda Consumer Healthcare Company (TCHC) is now operating as Alinamin Pharmaceutical Co following completion of the divestment to private-equity firm Blackstone.
25 August 2020
Private-equity firm Blackstone is acquiring Takeda’s Japanese OTC business, Takeda Consumer Healthcare Company (TCHC), in a deal worth around JPY242 billion (USD2.29 billion).
22 June 2020
Takeda may be close to divesting its Japanese OTC business, Takeda Consumer Healthcare Company, according to media reports.
15 June 2020
South Korean biopharmaceutical company Celltrion is acquiring a portfolio of prescription and OTC brands from Japan’s Takeda in a deal worth up to USD278 million.
24 April 2020
Danish pharmaceutical company Orifarm is acquiring a portfolio of OTC and prescription pharmaceuticals sold in Europe from Japan’s Takeda in a deal worth up to approximately USD670 million.
5 March 2020
Brazil’s Hypera Pharma is strengthening its presence in Latin America by acquiring a portfolio of OTC and pharmaceutical products – including the Neosaldina brand – from Japan’s Takeda for USD825 million. The deal comes soon after Hypera announced the purchase of the Buscopan and Buscofem brands in...
5 November 2019
Stada Arzneimittel is acquiring Takeda’s OTC portfolio in Russia and the Commonwealth of Independent States (CIS) in a deal worth USD660 million. The deal comes a day after the German company announced it was purchasing Czech consumer healthcare firm Walmark.
16 October 2019
Switzerland’s Acino is acquiring a portfolio of OTC and prescription pharmaceuticals from Japan’s Takeda in a deal worth more than USD200 million.